IVO Advocacy | Advocacy
19
archive,category,category-advocacy,category-19,ajax_updown_fade,page_not_loaded,,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Advocacy

Dr Jorn Dyerberg, a pioneer on the benefits of omega-3 fatty acids with respect to cardiovascular disease, presents his concerns about a recent opinion piece in the August 22, 2019 issue of Scientific American: The False Promise of Fish Oil Supplements. Read Dr Dyerberg’s item…

Understanding Recent Omega-3 Science

07 Dec 2018, Posted by IVO in Advocacy

In November 2018, three scientific studies were published that looked at various aspects of the effect of long-chain omega-3s on the risk of cardiovascular events: ASCEND, VITAL (looked at Vitamin D and Omega-3s) and REDUCE-IT. There was much discussion about the findings of each report…

GOED – Global Association for EPA and DHA Omega-3s – is a US-based not-for-profit trade association whose goals are similar to IVO: ensuring that “the industry is producing quality omega-3 products” and working to “increase consumption of omega-3s to adequate levels around the world.” Discover...